Pain management in intellectually disabled children: Assessment, treatment, and translational research

Abraham J Valkenburg1, Monique van Dijk, Annelies de Klein

  • 1Department of Pediatric Surgery and Pain Expertise Center, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands. a.valkenburg@erasmusmc.nl

Insights

Validated pain assessment tools exist for children with intellectual disabilities. Future research should focus on tailoring pain treatment through pharmacokinetic studies and genotype-phenotype analysis to develop specific analgesic algorithms.

Area of Science:

  • Medical Research
  • Pediatrics
  • Pain Management

Background:

  • Pain assessment in intellectually disabled children remains a primary research focus.
  • Existing observational pain scales vary in application and target populations.
  • Intellectually disabled children often have comorbidities and experience differential pain treatment.

Purpose of the Study:

  • To explore the integration of validated pain assessment and postoperative pain treatment in intellectually disabled children.
  • To determine the feasibility of developing specific analgesic algorithms for this population.

Main Methods:

  • Review of existing literature on pain assessment scales and treatment in intellectually disabled children.
  • Exploration of research gaps in pharmacological understanding and genotype-phenotype associations.
  • Identification of needs for future pharmacokinetic and pharmacodynamic studies.

Main Results:

  • Numerous validated observational pain assessment tools are available for intellectually disabled children.
  • Significant gaps exist in knowledge regarding drug interactions and pharmacological issues in this population.
  • Potential for genotype-phenotype associations in Down syndrome related to pain offers promising research avenues.

Conclusions:

  • Current pain assessment tools for intellectually disabled children are adequate.
  • There is a critical need to shift focus towards tailoring pain treatment strategies.
  • Pharmacokinetic/pharmacodynamic studies and genotype-phenotype research are essential for developing personalized analgesic algorithms.